Interpretation of arrhythmogenic effects of COVID-19 disease through ECG
We aimed to detect the malignant arrhythmic potential of COVID-19 with surface electrocardiographic (ECG) markers. Of the ECG parameters PR, QT, QTc, QTd, TPe, and Tpe/QTc were measured in 51 COVID-19 patients and 40 in control subjects. Compared to control group mean QTc (410.8 ± 24.3 msec vs. 394....
Saved in:
Published in: | The aging male Vol. 23; no. 5; p. 1362 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
01-12-2020
|
Subjects: | |
Online Access: | Get more information |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | We aimed to detect the malignant arrhythmic potential of COVID-19 with surface electrocardiographic (ECG) markers.
Of the ECG parameters PR, QT, QTc, QTd, TPe, and Tpe/QTc were measured in 51 COVID-19 patients and 40 in control subjects.
Compared to control group mean QTc (410.8 ± 24.3 msec vs. 394.6 ± 20.3 msec,
< .001) and Tpe/QTc (0.19 ± 0.02 vs. 0.18 ± 0.04,
= .036) and median QTd (47.52 vs. 46.5) values were significantly higher in COVID-19 patients. Troponin levels were significantly correlated with heart rate (
= 0.387,
= .006) but not with ECG parameters.
Several ventricular arrhythmia surface ECG predictors including QTc, QTd, and Tpe/QTc are increased in COVID-19 patients. Since medications used in COVID-19 patients have the potential to affect these parameters, giving importance to these ECG markers may have a significant contribution in decreasing disease-related arrhythmias. |
---|---|
ISSN: | 1473-0790 |
DOI: | 10.1080/13685538.2020.1769058 |